Rejuvenation after omental transplantation on the optic chiasma and carotid bifurcation

Case Reports and Clinical Practice Review

Volumn 7, Issue , 2006, Pages 48-51

  Rafael, Hernando ^a,b  

^a Sanatorio San Hipolito   (Mexico)

^b NONE   (Mexico)

Author keywords

Aging; Cerebral atherosclerosis; Omental transplantation; Rejuvenation

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLIPIZIDE;

AGED; ARTICLE; BRAIN DYSFUNCTION; CAROTID ARTERY BIFURCATION; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OMENTUM; OPTIC CHIASM; POSTOPERATIVE PERIOD; TISSUE TRANSPLANTATION;

EID: 33646517496     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rafael H, Moromizato P, Espinoza M, Talavera V. Functional recovery of the injured optic chiasma after omental transplantation. Turk Neurosurg 1999; 9: 68-72.
2. Rafael H, Mego R, Alcalá A. Visual improvement following omental transplantation on the ischemic optic chiasma. J Neurol Sci (Turk) 2003; 20(3); 185-188. www.jns.dergisi.org
3. Rafael H, Corea F, Moromizato P, Espinoza M. Hipertensión esencial y trasplante de epiplón al espacio perforado anterior. Hipertensión (Méx) 1999; 19(3): 42-45.
4. Rafael H. Isquemia hipotalámica por aterosclerosis y diabetes mellitus tipo 2. Climaterio 2004; 7(41): 192-197. www.revistasmedicas-mexicanas. com.mx
5. Rafael H, Mego R, Moromizato P, García W, Rodriguez J. Omental transplantation for type 2 diabetes mellitus. A report of two cases. Case Rep Clin Pract Rev 2004; 5: 481-486.
6. Rafael H. Intracranial anastomosis. J Neurosurg 2003; 98: 439-440 (letter).
7. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years. N Engl J Med 1990; 323: 1-6.
8. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman JW, Draper MW. Effects of human growth hormone on body composition in elderly men. Hormone Res 1991; 36(suppl 1): 73-81.
9. Corpas E, Harman MS, Blackman MR. Human growth hormone and human ageing. Endocrine Rev 1993; 14: 20-39.
10. Kerckoff H. Manejo de la somatotropina como terapia anti-envejecimiento. Climcaterio 2004; 7(42): 245-249.
11. Khrram O. Use of growth hormone and growth hormone secretagogues in aging: Help or harm. Clin Obst Gynecol 2001; 44: 893-901.
12. Vittone J, Blackman M, Busby-Whitehead J, et al. Effect of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healtly elderly men. Metabolism 1997; 46: 89-96.
13. Laron Z. Growth hormone secretagogues. Clinical experience and therapeutic potential. Drugs 1995; 50(4): 595-601.
14. Merriam GR, Schwartz RS, Vitiello MV. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endrocrine 2003; 22: 41-48.
15. Yujin S, Tamotsu S, Asuka O, et al. Hypothalamic growth horm, one secretagogues receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002; 109: 1429-1436.
16. Arvat E, Giordano R, Gianotti L, Broglio F, Cammnni F, Ghigo E. Neuroendocrinology of the human growth hormone-insulin-like growth factor I axis during ageing. Growth Horm IGF Res 1999; 9 : 111-115.
17. Locatelli V. Neurohormonas hipotalámicas. En, MüllerEE(ed). Neuroendocrinología: Aspectos experimentales y clínicos. Madrid: Asturasa Internacional 1987, pp 155-200.
18. Reichlin S. Neuroendocrinology. In, Wilson JD andFoster DW(eds). Williams texbook of endocrinology. Seventh edition. Philadelphia: W.B. Saunders Co. L985: 492-567.
19. Bailey AR, Smith RG, Leng G. The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus. J Neuroendocrinol 1998; 10: 111-118.
20. Leal S, Andrade JP, Paula-Barbosa MM, Madeira MD. Arcuate nucleus of the hypothalamus: Effects of age and sex. J Comp Neurol 1998; 401: 65-88.
21. Daniel PM. The blood supply of the hypothalamus and pituitary gland. Br Med Bull 1966; 22(3): 202-207.
22. Gibo H, Lenkey C, Rhoton ALJr. Microsurgical anatomy of the supraclinoid portion of the internal carotid artery. J Neurosurg 1981; 55: 560-574.
23. Flora GC, Baker AB, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859-869.
24. Kety SS. Human cerebral blood flow and oxygen consumption as related to aging. J Chronic Dis 1956; 3(5): 478-486.
25. Kety SS, The physiology of the cerebral circulation. In, Vinken PJ and Bruyn GH (eds). Handbook of clinical neurology. Vol 11. Part 1: Vascular diseases of the nervous system.Chapter 6. Amsterdam: North-Holland Publishing Co 1972, pp118-127.
26. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: Relation to age and adiposity. J Clin Invest 1981; 67(5): 1361-1369.
27. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adult with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
28. Vallareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA 2004; 98(2): 439-440.
29. Rafael H, Durán MA, Oviedo I. Isquemia pancreática por aterosclerosis y diabetes tipo 2. Climaterio 2002; 5(28): 184-187.
30. Herman A, Adar R, Rubinstein Z. Vascular lesions associated with impotence in diabetic and nondiabetic areterial occlusive disease. Diabetes 1978; 27: 975-981.